The neuropeptide receptor calcitonin receptor-like (CALCRL) is a potential therapeutic target in acute myeloid leukemia

Linus Angenendt(University Hospital Münster), Eike Bormann(University of Münster), Caroline Pabst(Heidelberg University), Vijay Alla(University Hospital Münster), Dennis Görlich(University of Münster), L.F. Braun(University Hospital Münster), Kim Dohlich(University Hospital Münster), Christian Schwöppe(University Hospital Münster), Stefan K. Bohlander(University of Auckland), Marı́a Francisca Arteaga(University Hospital Münster), Klaus Wethmar(University Hospital Münster), Wolfgang Hartmann(University Hospital Münster), Adrian Angenendt(Saarland University), Torsten Keßler(University Hospital Münster), Rolf M. Mesters(University Hospital Münster), Matthias Stelljes(University Hospital Münster), Maja Rothenberg‐Thurley(LMU Klinikum), Karsten Spiekermann(LMU Klinikum), Josée Hébert(Hôpital Maisonneuve-Rosemont), Guy Sauvageau(Hôpital Maisonneuve-Rosemont), Peter J.M. Valk(Erasmus University Rotterdam), Bob Löwenberg(Erasmus University Rotterdam), Hubert Serve(Goethe University Frankfurt), Carsten Müller‐Tidow(Heidelberg University), Georg Lenz(University Hospital Münster), Bernhard Wörmann(Charité - Universitätsmedizin Berlin), M. C. Sauerland(University of Münster), Wolfgang Hiddemann(LMU Klinikum), Wolfgang E. Berdel(University Hospital Münster), Utz Krug(Klinikum Leverkusen), Klaus H. Metzeler(LMU Klinikum), Jan‐Henrik Mikesch(University Hospital Münster), Tobias Herold(Helmholtz Zentrum München), Christoph Schliemann(University Hospital Münster)
Leukemia
June 10, 2019
Cited by 47Open Access
Full Text

Abstract


Related Papers